Knee pain is the single most common reason patients ask about exosome injection. The useful answer separates three things: why the joint is a plausible target, who is actually a candidate on imaging and examination, and how any response should be measured rather than assumed.
Why Joints Are Studied as a Target
- Degenerative joint pain involves persistent low-grade inflammation, not wear alone
- The joint is a contained space, so an injected preparation stays where it is placed
- Exosome cargo can influence inflammatory signalling in cartilage and synovium in laboratory models
- Delivery is a short outpatient procedure rather than surgery
Plausibility is not proof. The mechanism itself is described in our article on how exosome injections work.
Which Knees Are Assessed, and Which Are Not
Assessment is usually more favourable when:
- Imaging shows early to moderate rather than end-stage change
- Pain has an inflammatory pattern with swelling and stiffness episodes
- The joint is stable, with reasonable alignment and muscle control
- Conservative measures have been tried properly, not briefly
It is usually unfavourable when:
- Bone-on-bone change with deformity is present
- There is mechanical locking, instability or an untreated meniscal tear
- Symptoms arise mainly from the spine or hip rather than the knee itself
Structured assessment for these presentations is described on our joint pain treatment page.
Exosomes Compared With Other Joint Injections
| Option | What it delivers | Evidence maturity |
|---|---|---|
| Corticosteroid | Potent short-term anti-inflammatory effect | Well established, limited repeat use |
| Hyaluronic acid | Viscosupplementation of joint fluid | Established, variable results by patient |
| PRP | Autologous platelet growth factors | Substantial clinical literature, variable preparations |
| Exosomes | Cell-derived vesicles, no living cells | Early clinical stage, investigational |
| MSC injection | Viable mesenchymal stromal cells | More trial data than exosomes, still evolving |
Detailed knee-specific findings for cell therapy are summarised in our review of knee osteoarthritis and stem cell therapy.
What a Joint Protocol Looks Like in Practice
- Baseline examination, imaging review and a recorded function score
- Confirmation of lot documentation for the preparation used
- Sterile, often image-guided injection into the joint space
- Short observation, then activity modification for several days
- Rehabilitation guidance, which does more for outcomes than most patients expect
- Scheduled review at defined intervals, with the same score repeated
Loading and strengthening are not optional extras; without them, an injection is being asked to solve a problem it cannot solve alone.
Measuring Response Instead of Guessing
- A validated pain and function score recorded before treatment
- Objective measures such as walking distance or stair tolerance
- Analgesic use documented rather than recalled
- Review dates fixed in advance, not arranged only if the patient complains
- A written decision rule for whether anything is repeated
Without a baseline, improvement cannot be distinguished from a good week. That is the most common reason patients cannot tell whether an injection helped.
Where This Option Reaches Its Limits
- It does not restore lost cartilage or correct alignment
- It does not substitute for surgery in advanced structural disease
- Effects, where present, are described as temporary rather than permanent
- Preparations differ between providers, so results are not transferable
Where an injectable is not the right answer, orthopaedic and rehabilitation pathways through our clinical services remain the appropriate route.
Have Your Knee Assessed Before Choosing an Injection
Send your imaging and history for review, and our physicians will tell you which options are reasonable for your joint — including when none of them is. MRC Healthcare is a physician-led regenerative medicine group in Bangkok.
Schedule a Consultation
